Form 8-K Hims & Hers Health, Inc. For: May 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Leerink Reiterates Market Perform Rating on Hims and Hers (HIMS)
June 2, 2026 8:19 AM EDTLeerink analyst Michael Cherny reiterated a Market Perform rating and $25.00 price target on Hims and Hers (NYSE: HIMS).
The analyst comments "We are updating our HIMS estimates to reflect today's completion of the Eucalyptus acquisition and recent financing that is partially funding... More
